Danielle Gerhard, PhD | Mar 22, 2024 | 10+ min read
With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.
Sino Biological, Inc. (SZSE: 301047) has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products to BEI Resources, a central repository for reagents to support infectious disease research.
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
Biological Research Author: Holly Ahern It's the type of problem that crops up in cell biology, molecular biology, and neuroscience laboratories constantly. Hidden amid a compendium of compounds in a crude cell extract is a protein that researchers have sought since its gene was cloned months before. Perhaps the protein is an enzyme for which the catalytic mechanism has not yet been determined. Or maybe the compound is a recombinant protein that shows promise as a pharmaceutical agent. In eith
Laura Dattaro, Spectrum | Mar 10, 2023 | 4 min read
A wiring map diagrams more than half a million neuronal connections in the first complete connectome of Drosophila and holds clues about which brain architectures best support learning.